Lisata Therapeutics Inc

Research Lisata Therapeutics Inc (LSTA) on Bullrun: market cap USD 30.87M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLSTA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 30.87M
• Financial periodFY2025
• RevenueUSD 170.00K
• Revenue growth-83.0%
• Net income-USD 16.59M
• Free cash flow-USD 15.98M

Valuation Snapshot

latest market cap is USD 30.87M.

About Lisata Therapeutics Inc

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.

Frequently asked questions

What is Lisata Therapeutics Inc's market cap?

Lisata Therapeutics Inc's market capitalization is USD 30.87M.

What does Lisata Therapeutics Inc do?

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.